Oxford BioDynamics, Google Cloud Boost Precision Medicine
13 Aug 2025 //
CONTRACTPHARMA
Oxford Biodynamics To Present EpiSwitch At Clinical Biomarkers Summit
25 Jul 2024 //
BUSINESSWIRE
Oxford joins Strategic Government Initiative to advance Cancer Immunotherapy.
25 Jun 2024 //
BUSINESSWIRE
Oxford BioDynamics: High Accuracy Canine Cancer Diagnostic Test
04 Jun 2024 //
BUSINESSWIRE
Oxford Receives Reimbursement Code for EpiSwitch® Prostate Screening (PSE) Test
03 Oct 2023 //
BUSINESSWIRE
Oxford in San Francisco for the 41st Annual J.P. Morgan Healthcare Conference
19 Dec 2022 //
BUSINESSWIRE
DIRECTOR DEALINGS: PCA to Bellway chair buys GBP500,000 in shares
08 Apr 2022 //
ISE UK
Oxford BioDynamics Announces US Launch of EpiSwitch CiRT for Oncology
25 Feb 2022 //
BUSINESSWIRE
Oxford BioDynamics Awarded US FNIH Grant to Apply EpiSwitch® Immune Health Test
31 Aug 2021 //
BUSINESSWIRE

Market Place
Sourcing Support